This NCI-funded intensive 6-day workshop will provide an overview of fundamental methods, such as study designs, qualitative and survey methods, and approaches to data analysis in supportive oncology research. Over the course of the workshop, participants will write a complete study protocol under the direct mentorship of expert faculty in the field of supportive oncology. Participants will continue to receive assistance after the workshop from their workshop mentors to help in the implementation of their studies at their home institutions.
Essential workshop topics include: creation of conceptual models, epidemiological methods, supportive care clinical trials, development of psychosocial interventions, decision science, web-based research, study of patient-provider communication, qualitative and survey methods, and data analysis.
Jennifer Temel, MD and William Pirl, MD, MPH will co-chair the workshop with a multidisciplinary team of faculty including: Joseph Greer, PhD; Michael Fisch, MD, MPH; Elyse Park, MD, MPH; Lisa Wood, PhD; James Tulsky, MD; Marie Bakitas, DNSc, APRN and others.
- The workshop will take place January 22-27, 2017 at the Massachusetts General Hospital in Boston, MA.
- Participants will receive a stipend for travel and lodging, and the week-long course is free of charge.
- Attendance is limited to 36 participants and will be based on a competitive application process.
- For more information and to apply, please visit the workshop website: www.mghworkshop2017.com
- Applications are due by September 15, 2016.
- Physicians, nurses, social workers, and psychologists who are early-stage researchers are eligible to attend. Participants must have a doctoral degree or be a student in a doctoral program.
Please contact Lauren Fields (firstname.lastname@example.org) for questions or more information. Funded by NCI R25 CA181000
Do you or someone you know need tools to justify your department’s clinical research or clinical trials performance? METRICS WEBINAR SERIES by N2
Do you or someone you know need tools to justify your department’s clinical research or clinical trials performance? The N2 Metrics Webinar Series is here to help you. Using your own department or project, please join us for a three-part webinar series and bonus, in person meeting with the instructor (if you are in Toronto on February 5th).
Webinar #1: Foundation of Performance Metrics (Monday, Nov 2nd 2015 12:00-1:00pm EST)
- The Case for Effective Performance Metrics
- What’s an Effective Metric?
- Using Effective Metrics Effectively
- The MCC Metrics Definition Outline
Webinar #2: Process Maps and the Metrics Development Process (Thursday, Dec 3rd 2015 12:00-1:00pm EST)
- Mapping The Process Being Measured
- The MCC Metrics Development Process
- Metrics that Align with Organizational Levels.
Webinar #3: Metrics Visualization & Benchmarking Performance to Gain Valuable Insights (Monday, January 18th, 2016 12:00-1:00pm EST)
- The Case for Effective Metrics Visualizations
- Chart Type Strengths
- The Use of Effective Formatting
- Dashboard Tips
NOTE: If you cannot attend on these dates, no problem, they will be recorded and you can watch at a later date.
Bonus Ask the Professor Session: Linda Sullivan, the instructor will be holding a workshop on February 5th, 2015 after the N2 annual meeting in Toronto to help you finalize your project or answer your questions.
- $100 + tax per organization for all 3 Webinars
- includes 1 certificate ( 1hr SoCRA or ACRP credit per webinar )
- $250 per person
Download the N2 8th Annual Meeting-Newsletter (June 2015) here.
The Network of Networks (N2) is a not-for-profit incorporated organization and an alliance of Canadian research networks and organizations working to enhance national clinical research capability and capacity. Bringing together trialists and clinical research professionals from across the country, N2 provides a common platform for sharing best practices, resources and research-related content to ensure efficient and high-quality research, integrity of clinical practices and accountability. The organization is truly representative of clinical research in Canada and acts as a national voice and advocate on behalf of a broad range of stakeholders that have an impact on the efficiency and quality of clinical trials conducted in Canada.
C17 is a member of N2. For more information about N2, see their website www.n2canada.ca.
Dr. Joseph de Nanassy, MD FRCPC CCPE MCHM, Site Chief, Department of Laboratory Medicine & Division Chief, Anatomical Pathology, Children’s Hospital of Eastern Ontario, Ottawa, ON; Associate Professor, University of Ottawa; Member, POGO Pathology and Molecular Diagnostic Task Force
Date: Thursday, June 18, 2015
Time: 1:00 – 2:30 p.m. (60 minutes presentation; 30 minutes Q & A)
Audience: Pathologists, Pathology Fellows and Residents; Pediatric Oncologists, Surgeons, Radiation Oncologists; Clinical Research Associates (CRA’s). This webinar will provide expert advice for advancing pediatric oncology toward standardized reporting of pathology specimens; optimal pathology investigation; incremental clarity of clinical implications; and unprecedented analytics. Presented in partnership with the Canadian Partnership Against Cancer (CPAC)
As part of POGO’s long-range plan for childhood cancer in Ontario, a task force was initiated, co-chaired by Dr. Gino Somers, Head, Division of Pathology, Hospital for Sick Children, and Dr. David Malkin, POGO’s Medical Director, to determine reporting protocols currently in use, to review/ generate/ approve reporting templates and conventions, and to recommend future practice in Ontario. The task force identified and endorsed the pediatric College of American Pathologists’ (CAP) protocols and is recommending their adoption in Ontario.
- To review the CAP protocols related to Neuroblastoma and its use by pathologists specializing in pediatric oncology.
- To understand changes in the latest revision of the CAP cancer protocols and electronic cancer checklists.
Participation details: Please confirm your participation in this webinar at http://www.pogo.ca/education/synoptic-reporting/ to register online. For questions about registration, please contact Emily Bain at email@example.com or 416-592-1232 ext. 227. Webinar login details will be provided in advance of the event. Your confirmation by June 16 (at 5 p.m.) is suggested.
he New Investigator Clinical Trials Course (NICTC) is an important component of the NCIC Clinical Trials Group mandate to provide and facilitate investigator education and training. The major goal of this three-day course is to familiarize new investigators from across the country with the essentials of clinical trial conduct in the Canadian research environment.
The 2015 New Investigator Clinical Trials Course marks the fifth biennial year of the Course, which was founded in 2007. The next NICTC is scheduled for August 12-14, 2015 at the Donald Gordon Centre in Kingston. Applications are now being accepted.
Participants must be trainees/fellows and junior faculty members in their first five years of staff appointment in medical, hematologic, radiation and surgical oncology programs from across Canada.
Applicants are asked to provide a current curriculum vitae and their research interests as they relate to clinical trials, and to provide feedback on the draft agenda and suggestions for additional topics. The selection process will be based on the need for broad representation of the different subspecialties, and geographical distribution from across Canada.
Successful applicants will receive support from the NCIC CTG for travel and accommodation. Course material including faculty biographies, presentations, and session bibliographies will be made available to course participants on the NCIC CTG website.
For complete information about the course and to find an application form, please use this link … https://www.ctg.queensu.ca/newinv/default.html.
The CTSU is planning a webinar entitled, “Access to NCTN AYA Trials”, to highlight the need for sites to activate and offer cancer clinical trials to Adolescents and Young Adults (AYA). This webinar is set for Wednesday, April 22nd, 2015 at 4pm – 5pm EST.
NCI’s Dr. Nita Seibel will provide an overview on the NCTN AYA trials available on the CTSU, followed by a detailed summary of the COG-NRG ARST 1321 trial, (Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib), given by Study Co-Chair, Dr. Aaron Weiss from COG.
The agenda also will include:
- Suggestions from a few NCTN sites on how they’ve successfully opened AYA trials for both pediatric and adult patients.
- Information provided by NCI’s CIRB on their review processes for these trials and activation at sites treating pediatric or older adult patients.
- A brief recap by CTSU on site crediting for AYA trials.
The webinar will end with a Q&A session for you to ask questions from any of the webinar presenters about the trial and any issues regarding activating and accruing to AYA trials.
This webinar kicks off a new series of webinars by the CTSU. The goal of these webinars is to address key concerns that affect accrual to NCI-supported trials, and raise of awareness of trials among NCTN sites. The series is available to all sites and individuals interested in attending.
To attend the webinar on the NCTN AYA trials, simply go to the link below, and click register.
The Canadian Cancer Research Alliance’s 2015 Canadian Cancer Research Conference will be held November 8 to 10, 2015 at the Montréal Bonaventure.
Registration Now Open!
Discounted early bird registration for the conference is open until August 31, 2015. Regular registration
fees apply after August 31, 2015.
Submit Your Abstract
Abstract submission is open until May 15, 2015 for oral and poster presentations.
For further information, please visit our website: www.ccra-acrc.ca/conference.
The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals. This scholarship is offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation.
A maximum of $1000 CND will be awarded to each successful applicant. The educational program/conference must be completed by June 1, 2016.
The application form, including instructions and eligibility, can be found on the C17 website under committees>education
Applications are due May 8 2015
Vascular Anomalies 2015 for the Pediatric Hematologist / Oncologist: C17 Education Videoconference and Pediatric Oncology Group of Ontario Lecture Series Event
Denise Adams, MD
Marjory J. Johnson Chair of Vascular Tumor Translational Research; Professor of Clinical Pediatrics, University of Cincinnati College of Medicine; Medical Director of the Comprehensive Hemangiomas and Vascular Malformation Clinic;
Director, Hematology/Oncology Fellowship Program, Division of Oncology; Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center
Date: April 1, 2015; 12:00-1:00 pm EST
a. To classify high risk vascular anomalies into tumors or malformations.
b. To determine medical treatment options for High Risk Vascular Anomalies.
The C17 Educational Videoconferences is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada.
Credit certification: To obtain credit certification please make sure you complete, sign and submit your evaluation form and forward to firstname.lastname@example.org or fax 613-738-4828
Telehealth Registration: Cut-off date for site registration is March 30. Book a room with your institution’s Videoconference Department, contact Bryan Makara, Manager, Telemedicine email@example.com
Oncofertility has emerged as a new interdisciplinary approach to address the reproductive future of young men, women, and children facing a life-preserving but fertility threatening cancer diagnosis. The CKN Canadian Oncofertility Referral Network is a nationwide platform that links patients, physicians and fertility clinics to ensure time-sensitive needs are met in providing fertility options for young cancer patients as they embark on treatment. The goal is to create and foster a multidisciplinary dialogue between patients and their medical team about fertility sparing options. Linked here is an accessible educational information/resources page with topics such as:
- legal considerations
- fertility preservation options, including pediatric options
- adoption as a cancer survivor, including barriers (US perspective)
- parenthood after cancer
- informed consent
- educational materials for professionals, including flowcharts, slide decks, and review articles addressing background biology and options